SightfileU.S. market data from official filings

Companies › SEER

SEER INC (SEER)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001726445 · EDGAR filings · Updated 2026-07-28

SEER INC (SEER) has reported institutional ownership of 37.7%, with 57 institutional managers holding positions valued at $35.9M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Institutional ownership
37.7%
Institutional managers
57
Reported 13F value
$35.9M
Insider activity
20 trans.
−$374.3K net selling
Data flags
1 active
from SEC filings

Filings this week (4)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, SEER INC has 57 institutional holders and institutional ownership of 37.7%.

Insider activity

Insiders reported 20 transactions (0 buys, 9 sells) across 8 reporting insiders, with a net reported value of −$374.3K.

Data flags from SEC filings

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2025-07-08 (recurring since 2025-07-08) — source filing. The authoritative details are those stated in the filing itself.

Related companies

INSPIREMD INC (NSPR) · iBio Inc (IBIO) · PROTALIX BIOTHERAPEUTICS INC (PLX) · HUMACYTE INC (HUMA) · NUVECTIS PHARMA INC (NVCT) · FRACTYL HEALTH INC (GUTS)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.